McMillan Shakespeare Ltd
MMS: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|.D | LOCK|R%> | LOCK|?D!@M@ |
McMillan Shakespeare Earnings: Strong Yields, but Competition and Cyclical Risks Likely Neglected
McMillan Shakespeare's underlying net profit after tax for fiscal 2025 fell 4% to AUD 103 million. EBITDA margin reduced to 31% from 34%, or 32% excluding one-off costs.
